HAYLEE GUSTAFSON: Open Payments
NPI 1225610421 · NEBRASKA CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 15 payments from 8 companies in 2025. Trend: 2023 $357 · 2024 $530 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $112 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: JARDIANCE, LEQVIO, CAPLYTA, GEMTESA, MOUNJARO, OPSUMIT, VOQUEZNA, VRAYLAR.
Industry payments across NE — which companies pay providers there.
